CORRECTION OF DEFICIENT PHAGOCYTOSIS DURING ERYTHROPOIETIN TREATMENT IN MAINTENANCE HEMODIALYSIS-PATIENTS

被引:42
作者
VEYS, N
VANHOLDER, R
RINGOIR, S
机构
[1] Department of Nephrology, University Hospital, Ghent
关键词
ERYTHROPOIETIN; PHAGOCYTOSIS; HEMODIALYSIS;
D O I
10.1016/S0272-6386(12)80454-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Studies on the influence of erythropoietin (EPO) on granulocyte or monocyte function are scant. In this study, the effect of EPO on polymorphonuclear cell (PMN) respiratory burst activity was evaluated in a double-blind, placebocontrolled study in 22 patients on maintenance hemodialysis. As an index of phagocyte respiratory burst activity, the increase in 14CO2 production from labeled glucose-l-C, after challenge with latex and zymosan, was measured on predialysis whole blood samples, before and after EPO-treatment. As controls, 56 nonuremics and 49 non-EPO-treated hemodialysis patients were evaluated. Before EPO treatment 14CO2 production was depressed to 75.7% (latex) and 54.6% (zymosan) of healthy controls (P < 0.01). A marked improvement was observed after a mean treatment period of 4 months (latex, 115 ± 12 to 172 ± 14; zymosan,178 ± 19 to 412 ± 36 dpm/103 PMN, P < 0.01). Placebo treatment induced no changes. The improvement became more pronounced with prolongation of treatment. A significant correlation between hematocrit and 14CO2 production was observed in the EPO treatment group (latex: n = 44, r = 0.47, P < 0.05; zymosan: n = 44, r = 0.57, P < 0.001). No correlation was found with serum ferritin. We conclude that the depressed phagocyte glycolytic activity of hemodialyzed uremics is normalized during correction of anemia by EPO. This may be attributed to factors other than a reduction in the body iron stores. © 1992, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 29 条
[1]   CORRECTION OF METABOLIC DEFICIENCIES IN LEUKOCYTES OF PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE [J].
BAEHNER, RL ;
NATHAN, DG ;
KARNOVSKY, ML .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (05) :865-+
[2]  
Bartunkova J, 1989, Cas Lek Cesk, V128, P1332
[3]   GAMMA-INTERFERON IS ABLE TO ENHANCE THE OXIDATIVE-METABOLISM OF HUMAN-NEUTROPHILS [J].
BERTON, G ;
ZENI, L ;
CASSATELLA, MA ;
ROSSI, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 138 (03) :1276-1282
[4]  
BLUMBERG N, 1989, ARCH PATHOL LAB MED, V113, P246
[5]   IRON OVERLOAD IN HEMODIALYSIS-PATIENTS INCREASES THE RISK OF BACTEREMIA - A PROSPECTIVE-STUDY [J].
BOELAERT, JR ;
DANEELS, RF ;
SCHURGERS, ML ;
MATTHYS, EG ;
GORDTS, BZ ;
VANLANDUYT, HW .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (02) :130-134
[6]   RECOMBINANT ERYTHROPOIETIN REVERSES POLYMORPHONUCLEAR GRANULOCYTE DYSFUNCTION IN IRON-OVERLOADED DIALYSIS PATIENTS [J].
BOELAERT, JR ;
CANTINIEAUX, BF ;
HARIGA, CF ;
FONDU, PG .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (07) :504-507
[7]  
BOMMER J, 1987, LANCET, V1, P392
[8]  
BRUNO E, 1989, BLOOD, V73, P671
[9]   FACTORS AFFECTING PENTOSE PHOSPHATE PATHWAY ACTIVITY IN HUMAN RED-CELLS [J].
DAVIDSON, WD ;
TANAKA, KR .
BRITISH JOURNAL OF HAEMATOLOGY, 1972, 23 (03) :371-&
[10]  
DELANO BG, 1990, KIDNEY INT, V37, P292